stars 1 stars 2 stars 3

Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. We know what transplant means to patients, and we’re leading innovation to improve their experience. For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Read our Community Guidelines: https://bit.ly/3FQr7Wg

View Top Employees from Veloxis Pharmaceuticals, Inc.

Veloxis Pharmaceuticals, Inc. Questions

The Veloxis Pharmaceuticals, Inc. annual revenue was $39 million in 2024.

Mark Hensley is the CEO of Veloxis Pharmaceuticals, Inc..

120 people are employed at Veloxis Pharmaceuticals, Inc..

Veloxis Pharmaceuticals, Inc. is based in Cary, North Carolina.

The NAICS codes for Veloxis Pharmaceuticals, Inc. are [33, 54, 541711, 541, 54171, 5417].

The SIC codes for Veloxis Pharmaceuticals, Inc. are [37, 28].

Top Veloxis Pharmaceuticals, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users